Severe anemia with Sofosbuvir based therapy for Hepatitis C (HCV) recurrence post Liver transplantation on mycophenolate mofetil (MMF)

被引：0
|
作者：
Elsiesy, Hussien [1 ]
Ajlan, Aziza A. [1 ]
Aljedai, Ahmed [1 ]
Alarieh, Rania [1 ]
Al-Hamoudi, Waleed K. [1 ,2 ]
Alkortas, Delal [1 ]
Al Sebayel, Mohammed [1 ]
Broering, Dieter C. [1 ]
Abaalkhail, Faisal A. [1 ]
机构：
[1] King Faisal Specialist Hosp D, Riyadh, Saudi Arabia
[2] King Saud Univ, Riyadh, Saudi Arabia
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1032
引用
收藏
页码：702A / 703A
页数：2
相关论文
共 50 条
  • [41] Ductular Reaction in Hepatitis C Recurrence Post Liver Transplantation
    Prakoso, Emilia
    Kench, James G.
    Clouston, Andrew D.
    Bowen, David
    McCaughan, Geoffrey W.
    Shackel, Nicholas A.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S820 - S820
  • [42] Delay of hepatitis C recurrence in liver transplant recipients: Impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction
    Fasola, CG
    Netto, GJ
    Christensen, LL
    Molmenti, EP
    Sanchez, EQ
    Levy, MF
    Goldstein, RM
    Klintmalm, GB
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1561 - 1562
  • [43] FEASIBILITY AND EFFICACY OF SOFOSBUVIR-BASED ANTIVIRAL THERAPY BEFORE LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A MONOCENTRIC EXPERIENCE
    Strona, S.
    Martini, S.
    Arese, D.
    Sacco, M.
    Torrani-Cerenzia, M. R.
    Ottobrelli, A.
    Romagnoli, R.
    Tandoi, F.
    Balzola, F.
    Cocchis, D.
    Mirabella, S.
    Rizza, G.
    Salizzoni, M.
    Rizzetto, M.
    Saracco, G. M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 : E29 - E29
  • [44] Efficacy and Safety of Sofosbuvir Based Regimens for Treatment of Hepatitis C Recurrence after Living Donor Liver Transplantation
    Choudhary, N. S.
    Saigal, S.
    Saraf, N.
    Rastogi, A.
    Goja, S.
    Bhangui, P.
    Raut, V
    Srinivasan, T.
    Soin, A. S.
    [J]. TRANSPLANTATION, 2017, 101 (05) : 43 - 43
  • [45] Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation
    Khemichian, Saro
    Lee, Brian
    Kahn, Jeffrey
    Noureddin, Mazen
    Kim, Brian
    Harper, Tammy
    Esmailian, Yvonne
    Fong, Tse-Ling
    [J]. TRANSPLANTATION DIRECT, 2015, 1 (06):
  • [46] Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C
    Wiesner, RH
    Shorr, JS
    Steffen, BJ
    Chu, AH
    Gordon, RD
    Lake, JR
    [J]. LIVER TRANSPLANTATION, 2005, 11 (07) : 750 - 759
  • [47] Safety and Efficacy of Hepatitis C Therapy with Sofosbuvir and Simeprevir after Liver Transplantation
    Gutierrez, Julio A.
    Grigorian, Alla
    Carrion, Andres F.
    Schweitzer, Michael D.
    Avalos, Danny J.
    Bhamidimarri, Kalyan R.
    Peyton, Adam
    [J]. HEPATOLOGY, 2014, 60 : 545A - 545A
  • [48] Safety and efficacy of all-oral sofosbuvir-based regimens to treat HCV recurrence post-liver transplantation
    Alsabbagh, Mohammed Eyad Yaseen
    Hanouneh, Ibrahim A.
    John, Binu V.
    Guirguis, John K.
    Eghtesad, Bijan
    Fung, John J.
    Zein, Nizar N.
    Alkhouri, Naim
    [J]. HEPATOLOGY, 2014, 60 : 700A - 701A
  • [49] Mycophenolate's influence on recurrence and outcomes of hepatitis C following liver transplantation.
    Smallwood, GA
    Wallace, TM
    Davis, LP
    Stieber, AC
    Heffron, TG
    [J]. TRANSPLANTATION, 2000, 69 (08) : S313 - S313
  • [50] Novel Treatment for HCV Hepatitis Recurrence Post Liver Transplantation, Using Mizoribine.
    Takahara, Takeshi
    Nitta, Hiroyuki
    Hasegawa, Yasushi
    Itou, Naoko
    Takahashi, Masahiro
    Kimura, Yusuke
    Nishizuka, Satoshi
    Outuka, Kouki
    Koeda, Keisuke
    Sasaki, Akira
    Mizuno, Masaru
    Wakabayashi, Go
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S148 - S148
12345